Qiagen weighing sale of stake in $1B bioinformatics unit, Bloomberg says

Qiagen is working with advisers as it considers selling a minority stake in its bioinformatics unit in a deal that could value the business at more than $1B, sources tell Bloomberg’s Dinesh Nair, Michelle Davis and Tim Loh.